 | • レポートコード：QFJ1-4645 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、小児がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、腫瘍手術、血液・骨髄移植、薬物療法）、用途別市場規模（0〜15歳、15〜19歳）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・小児がん治療の市場動向 ・企業の競争状況、市場シェア ・小児がん治療の種類別市場規模と予測2016-2027（化学療法、放射線療法、腫瘍手術、血液・骨髄移植、薬物療法） ・小児がん治療の用途別市場規模と予測2016-2027（0〜15歳、15〜19歳） ・小児がん治療の北米市場規模2016-2027（アメリカ、カナダ） ・小児がん治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・小児がん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・小児がん治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・小児がん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（St Jude Children’s Research Hospital、St Louis Children’s Hospital、Monroe Carell Jr. Children’s Hospital at Vanderbilt、Birmingham Children’s Hospital、Royal Children’s Hospital、National Center for Child Health and Development、Dana-Dwek Children’s Hospital） ・結論 |
Children are affected by different forms of cancer than adults, there also exists a major difference between children and adults regarding treatment and development of new oncology therapies. The prominent variation is the concept of survival. With adult cancer patients, it is acceptable to look to immediate, 5 and 10-year survival rates, along with quality of life, for the best approximations of therapeutic success. On the other hand, a child cancer patient receives treatment to be cured. A typical difference between adult and pediatric oncologists is in treatment protocols; pediatric protocols are much more vigorous, often hitting patients “as hard as possible” to achieve a successful, long-term cure.
Market Analysis and Insights: Global Paediatric Oncology Therapeutics Market
The global Paediatric Oncology Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Paediatric Oncology Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Paediatric Oncology Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Paediatric Oncology Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Paediatric Oncology Therapeutics market.
Global Paediatric Oncology Therapeutics Scope and Market Size
Paediatric Oncology Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Paediatric Oncology Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
By Treatment
Chemotherapy
Radiotheraphy
Tumor Surgery
Blood and Marrow Transplantation
Drug Therapy
By Indication
Leukemia
Central Nervous System (CNS) disorders
Bone Tumors
Inflammatory disorders
Respiratory disorders
Retinoblastoma
Segment by Application
0-15 Years Old
15-19 Years Old
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
St Jude Children’s Research Hospital
St Louis Children’s Hospital
Monroe Carell Jr. Children’s Hospital at Vanderbilt
Birmingham Children’s Hospital
Royal Children’s Hospital
National Center for Child Health and Development
Dana-Dwek Children’s Hospital
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Paediatric Oncology Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Radiotheraphy
1.2.4 Tumor Surgery
1.2.5 Blood and Marrow Transplantation
1.2.6 Drug Therapy
1.3 Market by Application
1.3.1 Global Paediatric Oncology Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 0-15 Years Old
1.3.3 15-19 Years Old
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Paediatric Oncology Therapeutics Market Perspective (2016-2027)
2.2 Paediatric Oncology Therapeutics Growth Trends by Regions
2.2.1 Paediatric Oncology Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Paediatric Oncology Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Paediatric Oncology Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Paediatric Oncology Therapeutics Industry Dynamic
2.3.1 Paediatric Oncology Therapeutics Market Trends
2.3.2 Paediatric Oncology Therapeutics Market Drivers
2.3.3 Paediatric Oncology Therapeutics Market Challenges
2.3.4 Paediatric Oncology Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Paediatric Oncology Therapeutics Players by Revenue
3.1.1 Global Top Paediatric Oncology Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Paediatric Oncology Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Paediatric Oncology Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Paediatric Oncology Therapeutics Revenue
3.4 Global Paediatric Oncology Therapeutics Market Concentration Ratio
3.4.1 Global Paediatric Oncology Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Paediatric Oncology Therapeutics Revenue in 2020
3.5 Paediatric Oncology Therapeutics Key Players Head office and Area Served
3.6 Key Players Paediatric Oncology Therapeutics Product Solution and Service
3.7 Date of Enter into Paediatric Oncology Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Paediatric Oncology Therapeutics Breakdown Data by Type
4.1 Global Paediatric Oncology Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Paediatric Oncology Therapeutics Forecasted Market Size by Type (2022-2027)
5 Paediatric Oncology Therapeutics Breakdown Data by Application
5.1 Global Paediatric Oncology Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Paediatric Oncology Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Paediatric Oncology Therapeutics Market Size (2016-2027)
6.2 North America Paediatric Oncology Therapeutics Market Size by Type
6.2.1 North America Paediatric Oncology Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Paediatric Oncology Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Paediatric Oncology Therapeutics Market Size by Type (2016-2027)
6.3 North America Paediatric Oncology Therapeutics Market Size by Application
6.3.1 North America Paediatric Oncology Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Paediatric Oncology Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Paediatric Oncology Therapeutics Market Size by Application (2016-2027)
6.4 North America Paediatric Oncology Therapeutics Market Size by Country
6.4.1 North America Paediatric Oncology Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Paediatric Oncology Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Paediatric Oncology Therapeutics Market Size (2016-2027)
7.2 Europe Paediatric Oncology Therapeutics Market Size by Type
7.2.1 Europe Paediatric Oncology Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Paediatric Oncology Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Paediatric Oncology Therapeutics Market Size by Type (2016-2027)
7.3 Europe Paediatric Oncology Therapeutics Market Size by Application
7.3.1 Europe Paediatric Oncology Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Paediatric Oncology Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Paediatric Oncology Therapeutics Market Size by Application (2016-2027)
7.4 Europe Paediatric Oncology Therapeutics Market Size by Country
7.4.1 Europe Paediatric Oncology Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Paediatric Oncology Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Paediatric Oncology Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Paediatric Oncology Therapeutics Market Size by Type
8.2.1 Asia-Pacific Paediatric Oncology Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Paediatric Oncology Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Paediatric Oncology Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Paediatric Oncology Therapeutics Market Size by Application
8.3.1 Asia-Pacific Paediatric Oncology Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Paediatric Oncology Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Paediatric Oncology Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Paediatric Oncology Therapeutics Market Size by Region
8.4.1 Asia-Pacific Paediatric Oncology Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Paediatric Oncology Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Paediatric Oncology Therapeutics Market Size (2016-2027)
9.2 Latin America Paediatric Oncology Therapeutics Market Size by Type
9.2.1 Latin America Paediatric Oncology Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Paediatric Oncology Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Paediatric Oncology Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Paediatric Oncology Therapeutics Market Size by Application
9.3.1 Latin America Paediatric Oncology Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Paediatric Oncology Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Paediatric Oncology Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Paediatric Oncology Therapeutics Market Size by Country
9.4.1 Latin America Paediatric Oncology Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Paediatric Oncology Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Paediatric Oncology Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Paediatric Oncology Therapeutics Market Size by Type
10.2.1 Middle East & Africa Paediatric Oncology Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Paediatric Oncology Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Paediatric Oncology Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Paediatric Oncology Therapeutics Market Size by Application
10.3.1 Middle East & Africa Paediatric Oncology Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Paediatric Oncology Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Paediatric Oncology Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Paediatric Oncology Therapeutics Market Size by Country
10.4.1 Middle East & Africa Paediatric Oncology Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Paediatric Oncology Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 St Jude Children’s Research Hospital
11.1.1 St Jude Children’s Research Hospital Company Details
11.1.2 St Jude Children’s Research Hospital Business Overview
11.1.3 St Jude Children’s Research Hospital Paediatric Oncology Therapeutics Introduction
11.1.4 St Jude Children’s Research Hospital Revenue in Paediatric Oncology Therapeutics Business (2016-2021)
11.1.5 St Jude Children’s Research Hospital Recent Development
11.2 St Louis Children’s Hospital
11.2.1 St Louis Children’s Hospital Company Details
11.2.2 St Louis Children’s Hospital Business Overview
11.2.3 St Louis Children’s Hospital Paediatric Oncology Therapeutics Introduction
11.2.4 St Louis Children’s Hospital Revenue in Paediatric Oncology Therapeutics Business (2016-2021)
11.2.5 St Louis Children’s Hospital Recent Development
11.3 Monroe Carell Jr. Children’s Hospital at Vanderbilt
11.3.1 Monroe Carell Jr. Children’s Hospital at Vanderbilt Company Details
11.3.2 Monroe Carell Jr. Children’s Hospital at Vanderbilt Business Overview
11.3.3 Monroe Carell Jr. Children’s Hospital at Vanderbilt Paediatric Oncology Therapeutics Introduction
11.3.4 Monroe Carell Jr. Children’s Hospital at Vanderbilt Revenue in Paediatric Oncology Therapeutics Business (2016-2021)
11.3.5 Monroe Carell Jr. Children’s Hospital at Vanderbilt Recent Development
11.4 Birmingham Children’s Hospital
11.4.1 Birmingham Children’s Hospital Company Details
11.4.2 Birmingham Children’s Hospital Business Overview
11.4.3 Birmingham Children’s Hospital Paediatric Oncology Therapeutics Introduction
11.4.4 Birmingham Children’s Hospital Revenue in Paediatric Oncology Therapeutics Business (2016-2021)
11.4.5 Birmingham Children’s Hospital Recent Development
11.5 Royal Children’s Hospital
11.5.1 Royal Children’s Hospital Company Details
11.5.2 Royal Children’s Hospital Business Overview
11.5.3 Royal Children’s Hospital Paediatric Oncology Therapeutics Introduction
11.5.4 Royal Children’s Hospital Revenue in Paediatric Oncology Therapeutics Business (2016-2021)
11.5.5 Royal Children’s Hospital Recent Development
11.6 National Center for Child Health and Development
11.6.1 National Center for Child Health and Development Company Details
11.6.2 National Center for Child Health and Development Business Overview
11.6.3 National Center for Child Health and Development Paediatric Oncology Therapeutics Introduction
11.6.4 National Center for Child Health and Development Revenue in Paediatric Oncology Therapeutics Business (2016-2021)
11.6.5 National Center for Child Health and Development Recent Development
11.7 Dana-Dwek Children’s Hospital
11.7.1 Dana-Dwek Children’s Hospital Company Details
11.7.2 Dana-Dwek Children’s Hospital Business Overview
11.7.3 Dana-Dwek Children’s Hospital Paediatric Oncology Therapeutics Introduction
11.7.4 Dana-Dwek Children’s Hospital Revenue in Paediatric Oncology Therapeutics Business (2016-2021)
11.7.5 Dana-Dwek Children’s Hospital Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Paediatric Oncology Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Radiotheraphy
Table 4. Key Players of Tumor Surgery
Table 5. Key Players of Blood and Marrow Transplantation
Table 6. Key Players of Drug Therapy
Table 7. Global Paediatric Oncology Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Paediatric Oncology Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Paediatric Oncology Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Paediatric Oncology Therapeutics Market Share by Regions (2016-2021)
Table 11. Global Paediatric Oncology Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Paediatric Oncology Therapeutics Market Share by Regions (2022-2027)
Table 13. Paediatric Oncology Therapeutics Market Trends
Table 14. Paediatric Oncology Therapeutics Market Drivers
Table 15. Paediatric Oncology Therapeutics Market Challenges
Table 16. Paediatric Oncology Therapeutics Market Restraints
Table 17. Global Paediatric Oncology Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Paediatric Oncology Therapeutics Market Share by Players (2016-2021)
Table 19. Global Top Paediatric Oncology Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Paediatric Oncology Therapeutics as of 2020)
Table 20. Ranking of Global Top Paediatric Oncology Therapeutics Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Paediatric Oncology Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Paediatric Oncology Therapeutics Product Solution and Service
Table 24. Date of Enter into Paediatric Oncology Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Paediatric Oncology Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Paediatric Oncology Therapeutics Revenue Market Share by Type (2016-2021)
Table 28. Global Paediatric Oncology Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Paediatric Oncology Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Paediatric Oncology Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Paediatric Oncology Therapeutics Revenue Market Share by Application (2016-2021)
Table 32. Global Paediatric Oncology Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Paediatric Oncology Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Paediatric Oncology Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Paediatric Oncology Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Paediatric Oncology Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Paediatric Oncology Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Paediatric Oncology Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Paediatric Oncology Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Paediatric Oncology Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Paediatric Oncology Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Paediatric Oncology Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Paediatric Oncology Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Paediatric Oncology Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Paediatric Oncology Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Paediatric Oncology Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Paediatric Oncology Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Paediatric Oncology Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Paediatric Oncology Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Paediatric Oncology Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Paediatric Oncology Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Paediatric Oncology Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Paediatric Oncology Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Paediatric Oncology Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Paediatric Oncology Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Paediatric Oncology Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Paediatric Oncology Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Paediatric Oncology Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Paediatric Oncology Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Paediatric Oncology Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Paediatric Oncology Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Paediatric Oncology Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Paediatric Oncology Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 64. St Jude Children’s Research Hospital Company Details
Table 65. St Jude Children’s Research Hospital Business Overview
Table 66. St Jude Children’s Research Hospital Paediatric Oncology Therapeutics Product
Table 67. St Jude Children’s Research Hospital Revenue in Paediatric Oncology Therapeutics Business (2016-2021) & (US$ Million)
Table 68. St Jude Children’s Research Hospital Recent Development
Table 69. St Louis Children’s Hospital Company Details
Table 70. St Louis Children’s Hospital Business Overview
Table 71. St Louis Children’s Hospital Paediatric Oncology Therapeutics Product
Table 72. St Louis Children’s Hospital Revenue in Paediatric Oncology Therapeutics Business (2016-2021) & (US$ Million)
Table 73. St Louis Children’s Hospital Recent Development
Table 74. Monroe Carell Jr. Children’s Hospital at Vanderbilt Company Details
Table 75. Monroe Carell Jr. Children’s Hospital at Vanderbilt Business Overview
Table 76. Monroe Carell Jr. Children’s Hospital at Vanderbilt Paediatric Oncology Therapeutics Product
Table 77. Monroe Carell Jr. Children’s Hospital at Vanderbilt Revenue in Paediatric Oncology Therapeutics Business (2016-2021) & (US$ Million)
Table 78. Monroe Carell Jr. Children’s Hospital at Vanderbilt Recent Development
Table 79. Birmingham Children’s Hospital Company Details
Table 80. Birmingham Children’s Hospital Business Overview
Table 81. Birmingham Children’s Hospital Paediatric Oncology Therapeutics Product
Table 82. Birmingham Children’s Hospital Revenue in Paediatric Oncology Therapeutics Business (2016-2021) & (US$ Million)
Table 83. Birmingham Children’s Hospital Recent Development
Table 84. Royal Children’s Hospital Company Details
Table 85. Royal Children’s Hospital Business Overview
Table 86. Royal Children’s Hospital Paediatric Oncology Therapeutics Product
Table 87. Royal Children’s Hospital Revenue in Paediatric Oncology Therapeutics Business (2016-2021) & (US$ Million)
Table 88. Royal Children’s Hospital Recent Development
Table 89. National Center for Child Health and Development Company Details
Table 90. National Center for Child Health and Development Business Overview
Table 91. National Center for Child Health and Development Paediatric Oncology Therapeutics Product
Table 92. National Center for Child Health and Development Revenue in Paediatric Oncology Therapeutics Business (2016-2021) & (US$ Million)
Table 93. National Center for Child Health and Development Recent Development
Table 94. Dana-Dwek Children’s Hospital Company Details
Table 95. Dana-Dwek Children’s Hospital Business Overview
Table 96. Dana-Dwek Children’s Hospital Paediatric Oncology Therapeutics Product
Table 97. Dana-Dwek Children’s Hospital Revenue in Paediatric Oncology Therapeutics Business (2016-2021) & (US$ Million)
Table 98. Dana-Dwek Children’s Hospital Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Paediatric Oncology Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Radiotheraphy Features
Figure 4. Tumor Surgery Features
Figure 5. Blood and Marrow Transplantation Features
Figure 6. Drug Therapy Features
Figure 7. Global Paediatric Oncology Therapeutics Market Share by Application: 2020 VS 2027
Figure 8. 0-15 Years Old Case Studies
Figure 9. 15-19 Years Old Case Studies
Figure 10. Paediatric Oncology Therapeutics Report Years Considered
Figure 11. Global Paediatric Oncology Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Paediatric Oncology Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Paediatric Oncology Therapeutics Market Share by Regions: 2020 VS 2027
Figure 14. Global Paediatric Oncology Therapeutics Market Share by Regions (2022-2027)
Figure 15. Global Paediatric Oncology Therapeutics Market Share by Players in 2020
Figure 16. Global Top Paediatric Oncology Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Paediatric Oncology Therapeutics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Paediatric Oncology Therapeutics Revenue in 2020
Figure 18. Global Paediatric Oncology Therapeutics Revenue Market Share by Type (2016-2021)
Figure 19. Global Paediatric Oncology Therapeutics Revenue Market Share by Type (2022-2027)
Figure 20. North America Paediatric Oncology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Paediatric Oncology Therapeutics Market Share by Type (2016-2027)
Figure 22. North America Paediatric Oncology Therapeutics Market Share by Application (2016-2027)
Figure 23. North America Paediatric Oncology Therapeutics Market Share by Country (2016-2027)
Figure 24. United States Paediatric Oncology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Paediatric Oncology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Paediatric Oncology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Paediatric Oncology Therapeutics Market Share by Type (2016-2027)
Figure 28. Europe Paediatric Oncology Therapeutics Market Share by Application (2016-2027)
Figure 29. Europe Paediatric Oncology Therapeutics Market Share by Country (2016-2027)
Figure 30. Germany Paediatric Oncology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Paediatric Oncology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Paediatric Oncology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Paediatric Oncology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Paediatric Oncology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Paediatric Oncology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Paediatric Oncology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Paediatric Oncology Therapeutics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Paediatric Oncology Therapeutics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Paediatric Oncology Therapeutics Market Share by Region (2016-2027)
Figure 40. China Paediatric Oncology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Paediatric Oncology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Paediatric Oncology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Paediatric Oncology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Paediatric Oncology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Paediatric Oncology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Paediatric Oncology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Paediatric Oncology Therapeutics Market Share by Type (2016-2027)
Figure 48. Latin America Paediatric Oncology Therapeutics Market Share by Application (2016-2027)
Figure 49. Latin America Paediatric Oncology Therapeutics Market Share by Country (2016-2027)
Figure 50. Mexico Paediatric Oncology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Paediatric Oncology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Paediatric Oncology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Paediatric Oncology Therapeutics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Paediatric Oncology Therapeutics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Paediatric Oncology Therapeutics Market Share by Country (2016-2027)
Figure 56. Turkey Paediatric Oncology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Paediatric Oncology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Paediatric Oncology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. St Jude Children’s Research Hospital Revenue Growth Rate in Paediatric Oncology Therapeutics Business (2016-2021)
Figure 60. St Louis Children’s Hospital Revenue Growth Rate in Paediatric Oncology Therapeutics Business (2016-2021)
Figure 61. Monroe Carell Jr. Children’s Hospital at Vanderbilt Revenue Growth Rate in Paediatric Oncology Therapeutics Business (2016-2021)
Figure 62. Birmingham Children’s Hospital Revenue Growth Rate in Paediatric Oncology Therapeutics Business (2016-2021)
Figure 63. Royal Children’s Hospital Revenue Growth Rate in Paediatric Oncology Therapeutics Business (2016-2021)
Figure 64. National Center for Child Health and Development Revenue Growth Rate in Paediatric Oncology Therapeutics Business (2016-2021)
Figure 65. Dana-Dwek Children’s Hospital Revenue Growth Rate in Paediatric Oncology Therapeutics Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
世界の小児痙縮治療市場規模・現状・予測（2021年-2027年） Pediatric Spasticity results due to damage of portion of brain or spinal cord which controls the voluntary movement. When pediatric spasticity occurs due to injury or disease, nerve signals do not reach muscles and continuously contract which causes stiffness and tightness which interfere with movem…- 世界の小児放射線治療市場規模・現状・予測（2021年-2027年） Paediatric radiology is a subspecialty of radiology involving the imaging of fetuses, infants, children adolescents and young adults. Although some diseases seen in paediatrics are the same as that in adults, there are many conditions which are seen only in infants. The specialty has to take in acco…
- 世界の動物腫瘍市場規模・現状・予測（2021年-2027年） Veterinary oncology is a subspecialty of veterinary medicine that deals with cancer diagnosis and treatment in animals. Increasing pervasiveness of cancer in pet population and rising adoption of veterinary cancer therapy as a treatment method are propelling the market growth. Market Analysis and In…
- 世界の腫瘍血液検査市場規模・現状・予測（2021年-2027年） Oncology blood testing is a revolutionary diagnostic technique to detect cancer in early stages. For early detection of cancer, liquid biopsies have become a popular diagnostic tool. Market Analysis and Insights: Global Oncology Blood Testing Market The global Oncology Blood Testing market size is p…
- 世界の移植治療薬市場規模・現状・予測（2021年-2027年） Transplantation is the transfer (engraftment) of human cells, tissues, or organs from a donor to a recipient, with the aim of restoring function(s) in the body. Market Analysis and Insights: Global Transplantation Therapeutics Drugs Market The global Transplantation Therapeutics Drugs market size is…